Universitair Ziekenhuis Leuven (BE)
Access 250+ million papers and cite this researcher's work with AI assistance
H-index
182
Publications
2354
Citations
185023
i10-index
930
Want to find and read papers by this researcher? AnswerThis gives you instant access.
Sign Up Free| Title | Year | Citations |
|---|---|---|
Trastuzumab in combination with chemotherapy versu... | 2010 | 7316 |
Increased Survival in Pancreatic Cancer with nab-P... | 2013 | 6707 |
Cetuximab Monotherapy and Cetuximab plus Irinoteca... | 2004 | 5059 |
Cetuximab and Chemotherapy as Initial Treatment fo... | 2009 | 3882 |
ESMO consensus guidelines for the management of pa... | 2016 | 3419 |
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroe... | 2017 | 3297 |
Wild-Type KRAS Is Required for Panitumumab Efficac... | 2008 | 3209 |
Pembrolizumab in Microsatellite-Instability–High A... | 2020 | 3058 |
Regorafenib monotherapy for previously treated met... | 2012 | 2891 |
Everolimus for Advanced Pancreatic Neuroendocrine ... | 2011 | 2880 |
Eric Van Cutsem is a researcher with 2354 publications and 185023 citations. They are affiliated with Universitair Ziekenhuis Leuven. Their research focuses on . With an h-index of 182, they are among the top researchers in their field.
Distribution of citations across publications
AnswerThis uses AI to help you search, understand, and cite research from Eric Van Cutsem and 250M+ other papers.
Citations per publication by year